Evidence map›Paper›PMID 41293162›Full record

ReviewFrontiers in immunology2025

Interaction between gut microbiota and immunity in health and intestinal disease.

Qishang Wang, Qingguo Meng, Yuchao Chen, Yaxin Liu, Xinru Li, Jinjie Zhou, Yuchu Ma, Zihan Yu, Xin Chen

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Review
  3. AMarine drugs · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Foods (Basel, Switzerland) · 2026
    Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Frontiers in cellular and infection microbiology · 2026
    Article
  18. Article
  19. The hallmarks of host-microbiome decoupling.Frontiers in microbiology · 2026
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Qishang Wang *Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin, China.
Qingguo Meng *Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin, China.
Yuchao Chen *Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin, China.
Yaxin LiuDepartment of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin, China.
Xinru LiDepartment of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin, China.
Jinjie ZhouDepartment of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin, China.
Yuchu MaDepartment of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin, China.
Zihan YuDepartment of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin, China.
Xin ChenDepartment of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gut microbiota plays a fundamental role in establishing and maintaining host immune homeostasis through dynamic, bidirectional interactions with the innate and adaptive immune systems. This review synthesizes current knowledge on how commensal microbes guide the development and function of the intestinal immune system. Conversely, we examine how the host immune system, including immunoglobulin A (IgA) and T-cell responses, actively shapes microbial composition and colonization resistance. Disruptions in this equilibrium (dysbiosis) are critically implicated in pathogenesis. We explore the dysbiosis-immune axis in inflammatory bowel diseases (IBD), irritable bowel syndrome (IBS), and colorectal cancer (CRC), highlighting how specific microbial taxa and their metabolites influence disease progression through immune modulation. Furthermore, we discuss how acute infectious insults model the breakdown of this mutualism.

Indexed as

Gastrointestinal MicrobiomeIntestinal DiseasesAnimalsDysbiosisHumansInflammatory Bowel DiseasesIrritable Bowel Syndromeadaptive and innate immunitydysbiosisgut microbiotaimmune homeostasisintestinal disease

Identifiers

PMID41293162
PMCPMC12641010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.